Opioid Abuse (Disorder)J-ECHO OPSNCT07637994
Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes
A study testing Project ECHO in people with Opioid Abuse (Disorder), run by University of Massachusetts, Worcester at 1 site in United States.
Trial summary
This project tests a training strategy to help rural jails start or increase their use of medications to treat opioid use disorder (MOUD - methadone, buprenorphine, naltrexone). Staff from participating jails will attend a series of training sessions, called Project ECHO, that include online learning sessions with… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Opioid Abuse (Disorder)
- What is being tested?
- Project ECHO
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jan 2027to 31 May 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Administrative, security, or healthcare staff in participating jails
- Employed at the facility a minimum of 3 months
Who cannot join
- Ongoing or recent participation in similar organizational improvement project
- Inability to read or understand English or Spanish
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
UMass Chan Medical School
Worcester, Massachusetts, 01655
JCOIN ECHO Coordinator, 508-856-3515, jcoinecho@umassmed.edu
Rosemarie Martin, PhD
About this study
This project tests a training strategy to help rural jails start or increase their use of medications to treat opioid use disorder (MOUD - methadone, buprenorphine, naltrexone). Staff from participating jails will attend a series of training sessions, called Project ECHO, that include online learning sessions with skilled experts, case-based discussions (real-world examples), and peer-to-peer learning opportunities. Project ECHO is well-studied in healthcare settings but has rarely been used in correctional systems. Staff from 40 rural jails and local treatment programs will participate in 6 months of core sessions (all participants attend the same sessions), followed by 12 months of continuing sessions (where content is tailored to participants' needs). Staff will complete surveys about their knowledge and experience, and jails will provide data about their services. Researchers will measure changes in MOUD services offered by the jails over time, as well as the impact these changes have on staff's work environment. If Project ECHO helps expand MOUD services, it will offer a blueprint for expanding these life-saving services in other jails nationwide.
- Conditions
- Opioid Abuse (Disorder)
- Being tested
- Project ECHO
- Keywords
- Medications for Opioid Use Disorder, Rural Jails
- Medical subject headings
- Opioid-Related Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Project ECHOBehavioural
Virtual learning sessions, case-based discussions, and peer-to-peer learning
| Study group | Role | What they receive |
|---|---|---|
| ECHO | Experimental | Subjects participate in a series of facilitated ECHO learning sessions Receives: Behavioral: Project ECHO |
What is being measured
The primary outcome is the main question the study is designed to answer.
Increase in MOUD prescriptions (administrative data)
Administrative data tracking the number of MOUD prescriptions will be used to assess whether the jail has increased its use of MOUD to treat opioid use disorder relative to baseline.
Measured: From baseline through the end of sustainment phase (18 months)
Secondary outcomes (6)
Organizational climate - Burnout (BAT-4)
Staff surveys measure Burnout via the 4-item Burnout Assessment Tool (BAT-4). Items are scored from 1 (never) to 5 (always), and the mean is calculated (higher scores = greater burnout). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.
Measured: From baseline to end of sustainment period (18 months)
Organizational climate - Stress (TCU SOF subscale)
Staff surveys measure Stress via a validated 4-item subscale of the TCU Survey of Organizational Functioning. Items are scored from 1 (disagree) to 5 (agree), and the mean is calculated (higher scores = greater perceived stress). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.
Measured: From baseline through end of sustainment period (18 months)
Organizational climate - Job Satisfaction (TCU SOF subscale)
Staff surveys measure job satisfaction using a 6-item validated subscale from the TCU Survey of Organizational Functioning. Items are scored from 1 (strongly disagree) to 5 (strongly agree), and the mean is calculated (higher scores = greater job satisfaction). Change relative to baseline indicates impact of the intervention on this feature of organizational climate.
Measured: From baseline through end of sustainment period (18 months)
Impact on Staff Knowledge: Opinions About MAT Questionnaire
Staff surveys include this 12-item scale, measuring familiarity, receipt of training, and perceived effectiveness of 4 formulations of medications for opioid use disorder. Each item is rated on a 1-5 scale, with higher scores reflecting stronger endorsement. Overall improvements in any of the 3 domains relative to baseline will indicate the intervention had a positive impact on staff knowledge about MOUD.
Measured: From baseline through end of sustainment period (18 months)
Disciplinary infractions (administrative data)
Administrative data on the number and type of disciplinary infractions in past 6 months will assess the impact of MOUD service expansion on jail operations. Infractions are recorded as violent infractions; non-violent infractions; and instances of MOUD diversion.
Measured: From baseline through end of sustainment phase (18 months)
Improvement on Opioid Services Cascade (BJS survey module)
The BJS survey of opioid use disorder screening and treatment (supplement to the 2019 Annual Survey of Jails) measures service delivery (yes/no) using 12 items across 6 domains. An overall score is calculated by summing these responses, with higher scores relative to baseline indicating greater improvements in opioid treatment service delivery.
Measured: From baseline through end of sustainment period (18 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jun 2026
- Study start1 Jan 2027 (estimated)
- Primary completion28 Feb 2030 (estimated)
- Study completion31 May 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Opioid Abuse (Disorder)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Massachusetts, Worcester
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Responsible party
- Principal investigator, Rosemarie Martin, University of Massachusetts, Worcester
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07637994
- Sponsor's protocol ID
- STUDY00002674
- Other IDs
- RM1DA064507
- Acronym
- J-ECHO OPS
- Status last verified
- Oct 2026
- First submitted
- 16 May 2026
- Last updated
- 19 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Deidentified data from responses to staff surveys
Study at a glance
From the registry record, last updated by the sponsor on 19 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes
- ClinicalTrials.gov ID
- NCT07637994
- Acronym / sponsor ID
- J-ECHO OPS / STUDY00002674
- Conditions
- Opioid Abuse (Disorder)
- Keywords
- Medications for Opioid Use Disorder, Rural Jails
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- University of Massachusetts, WorcesterUniversity, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Study start
- 1 Jan 2027 (estimated)
- Primary completion
- 28 Feb 2030 (estimated)
- Study completion
- 31 May 2030 (estimated)
- First posted
- 10 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project tests a training strategy to help rural jails start or increase their use of medications to treat opioid use disorder (MOUD - methadone, buprenorphine, naltrexone). Staff from participating jails will attend a series of training sessions, called Project ECHO, that include online learning sessions with skilled experts, case-based discussions (real-world examples), and peer-to-peer learning opportunities. Project ECHO is well-studied in healthcare settings but has rarely been used in correctional systems. Staff from 40 rural jails and local treatment programs will participate in 6 months of core sessions (all participants attend the same sessions), followed by 12 months of continuing sessions (where content is tailored to participants' needs). Staff will complete surveys about their knowledge and experience, and jails will provide data about their services. Researchers will measure changes in MOUD services offered by the jails over time, as well as the impact these changes have on staff's work environment. If Project ECHO helps expand MOUD services, it will offer a blueprint for expanding these life-saving services in other jails nationwide.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ECHO | Experimental | Behavioral: Project ECHOSubjects participate in a series of facilitated ECHO learning sessions |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Administrative, security, or healthcare staff in participating jails
- Employed at the facility a minimum of 3 months
Key exclusion criteria (2 listed)
- Ongoing or recent participation in similar organizational improvement project
- Inability to read or understand English or Spanish
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Project ECHOVirtual learning sessions, case-based discussions, and peer-to-peer learning | Behavioural | ECHO |
Primary outcome
Increase in MOUD prescriptions (administrative data)
Time frame: From baseline through the end of sustainment phase (18 months)
Administrative data tracking the number of MOUD prescriptions will be used to assess whether the jail has increased its use of MOUD to treat opioid use disorder relative to baseline.
6 secondary outcomes
Organizational climate - Burnout (BAT-4)
Time frame: From baseline to end of sustainment period (18 months)
Organizational climate - Stress (TCU SOF subscale)
Time frame: From baseline through end of sustainment period (18 months)
Organizational climate - Job Satisfaction (TCU SOF subscale)
Time frame: From baseline through end of sustainment period (18 months)
Impact on Staff Knowledge: Opinions About MAT Questionnaire
Time frame: From baseline through end of sustainment period (18 months)
Disciplinary infractions (administrative data)
Time frame: From baseline through end of sustainment phase (18 months)
Improvement on Opioid Services Cascade (BJS survey module)
Time frame: From baseline through end of sustainment period (18 months)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Oct 2026.
- Individual participant dataSharing planned: Yes. Deidentified data from responses to staff surveys
Related trials for Opioid Abuse (Disorder)
Active, not recruiting
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
Opioid Dependence, Substance Abuse Disorders
Not yet recruitingPhase 1
Cannabis Effects on Opioid Self-Administration
Opioid Use Disorder, Cannabis Use
Not yet recruitingPhase 1
Cannabis and Opioid Use Disorder, Study 2
Opioid Use Disorders, Cannabis Use
Enrolling by invitationPhase 4
Reducing Opioid Use After Upper Extremity Surgery: Testing Lower Prescriptions and Pill Quantity
Opioid Abuse (Disorder), Opioid Analgesia
Not yet recruiting
Clinician Practice Companion to Address Youth Substance Use
Substance Use, Substance-Related Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Project ECHO in people with Opioid Abuse (Disorder), run by University of Massachusetts, Worcester at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact JCOIN ECHO Coordinator (508-856-3515, jcoinecho@umassmed.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Increase in MOUD prescriptions (administrative data) (time frame: From baseline through the end of sustainment phase (18 months)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026; AzTrials last refreshed its copy on 26 Oct 2026.